Novel Mini‐Hemagglutinin Subunit Vaccine Induces Robust Mucosal and Systemic Immunity and Protection Against a Lethal Challenge With the H1N1 and H5N1 Influenza Viruses in Mice
Journal of Medical Virology · 2025-10 · 97 (10)
DOI: 10.1002/jmv.70614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 23.09.2025. Verfasst von Tangqi Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Key Laboratory of Biosafety, National Health Commissions, Na…. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza A Virus, H1N1 Subtype, Orthomyxoviridae Infections, Influenza A Virus, H5N1 Subtype. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: This study was supported by the National Key Research and Development Program of China (2022YFC2304101 and 2021YFA1201003) and the National Natural Science Fou….
Abstract (Originalsprache)
Conventional influenza vaccines target the globular head domains of hemagglutinins (HAs), which are highly plastic and provide strain‐specific immunity. Therefore, a universal influenza vaccine with conserved antigens and novel adjuvants is urgently required. Mucosal immunity is the first line of defense against viral infections; however, proven mucosal adjuvants are lacking. Therefore, we developed an intranasal Mini‐HA subunit vaccine combined with the CTA1‐DD adjuvant, which elicited robust mucosal and systemic immune responses in the lungs and spleens of mice, including antigen‐specific IgA, IgG, and effector T cells. Furthermore, the Mini‐HA subunit vaccine provided the mice with cross‐protection against H1N1 and H5N1 influenza viruses. These results indicate that combining the Mini‐HA antigen and mucosal adjuvant CTA1‐DD is a promising strategy for developing broad‐spectrum influenza vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Key Laboratory of Biosafety, National Health Commissions, National Institute for Viral Disease Control and Prevention, Beijing, Ch…
- Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
- School of Public Health, Xinxiang Medical University, Xinxiang, China.
ORCID-Profile: Wenjie Tan
Förderung
- This study was supported by the National Key Research and Development Program of China (2022YFC2304101 and 2021YFA1201003) and the National Natural Science Fou…
Zitieren
APA
Wang, T., Han, R., Li, J., Cheng, X., Qi, Z., Bing, J., Zhai, C., Wang, D., Deng, Y., & Tan, W. (2025). Novel Mini‐Hemagglutinin Subunit Vaccine Induces Robust Mucosal and Systemic Immunity and Protection Against a Lethal Challenge With the H1N1 and H5N1 Influenza Viruses in Mice. Journal of Medical Virology, 97(10). https://doi.org/10.1002/jmv.70614
Vancouver
Wang T, Han R, Li J, Cheng X, Qi Z, Bing J, et al. Novel Mini‐Hemagglutinin Subunit Vaccine Induces Robust Mucosal and Systemic Immunity and Protection Against a Lethal Challenge With the H1N1 and H5N1 Influenza Viruses in Mice. Journal of Medical Virology. 2025;97(10). doi:10.1002/jmv.70614
BibTeX
@article{Wang2025,
author = {Wang, Tangqi and Han, Ruiwen and Li, Jia and Cheng, Xueting and Qi, Zhenyong and Bing, Jialuo and Zhai, Chengcheng and Wang, Donghong and Deng, Yao and Tan, Wenjie},
title = {Novel Mini‐Hemagglutinin Subunit Vaccine Induces Robust Mucosal and Systemic Immunity and Protection Against a Lethal Challenge With the H1N1 and H5N1 Influenza Viruses in Mice},
journal = {Journal of Medical Virology},
year = {2025},
volume = {97},
number = {10},
doi = {10.1002/jmv.70614}
}
EUVIMED